A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma
Angrilli, F.; Pennese, E.; Di Marzio, A.; Liberatore, E.; Di Lorenzo, R.; Fioritoni, G.
Haematologica 87(11): 1227-1229
2002
ISSN/ISBN: 0390-6078 PMID: 12414356 Document Number: 550204
We treated 30 consecutive untreated patients aged > 70 years with advanced aggressive non-Hodgkin's lymphoma with 6 courses of cyclophosphamide, mitoxantrone, etoposide, bleomycin, vinblastine and dexamethasone (D-VICEMB). The global response was 93%. The 6-year overall survival and progression-free survival were 50%, and disease-free survival was 63%.
Document emailed within 1 workday
Related Documents
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Ohnoshi, T.; Hayashi, K.; Mizuta, J.; Tagawa, S.; Matsutomo, S.; Saito, S.; Kawashima, K.; Akagi, T.; Kimura, I. 1993: Brief induction chemotherapy followed by involved-field irradiation for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma International Journal of Hematology 57(1): 61-66
Raina, V.; Sharma, A.; Mohanti, B.K.; Kumar, R.; Dawar, R.; Rath, G.K. 2003: Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease National Medical Journal of India 16(4): 199-203
Picozzi, V.J.; Pohlman, B.L.; Morrison, V.A.; Lawless, G.D.; Lee, M.W.; Kerr, R.O.; Ford, J.M.; Delgado, D.J.; Fridman, M.; Carter, W.B. 2001: Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma Oncology 15(10): 1296-1306; Discussion: 1310-1311, 1314
Jones, A.L.; Holborn, J.; Ashley, S.; Smith, I.E. 1991: Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide European Journal of Cancer 27(7): 866-870
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Itami, J.; Ogata, H.; Miura, K.; Yasuda, S.; Arimizu, N.; Tamaru, J.; Mikata, A. 1988: Non-Hodgkin's lymphoma in patients aged 70 or older Gan no Rinsho. Japan Journal of Cancer Clinics 34(7): 836-840
Athanassiou, A.E.; Potamianou, A.; Bountouroglou, N.; Ziras, N.; Frangoulidis, A.; Varthalitis, J.; Karvounis, N.; Chrysanthou, C.; Pectasidis, D. 2002: Methotrexate, etoposide, ifosfamide and cisplatin (MVIP): an effective first-line therapy for IGCCC intermediate / poor prognosis patients with germ-cell tumors. Single institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 7(1): 35-41
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Olopade, O.I.; Larson, R.A.; Mick, R.; Watson, S.M.; Hoffman, P.C.; Ultmann, J.E.; Golomb, H.M. 1990: Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP Leukemia 4(2): 127-131
Numbenjapon, T.; Sriswasdi, C.; Mongkonsritragoon, W.; Leelasiri, A.; Prayoonwiwat, W. 2002: Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma Journal of the Medical Association of Thailand 85(11): 1156-1163
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Cyriac, S.; Rajendranath, R.; Sridevi, V.; Sagar, T.G. 2011: Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy Journal of Reproductive Medicine 56(5-6): 219-223
Cagayan, M.S.F.S. 2012: High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy Journal of Reproductive Medicine 57(5-6): 231-236
Al-Mansour, M.; Al-Maghraby, H.; Shirah, B. 2020: Transformation of Grade i Follicular Lymphoma to Anaplastic Large Cell Lymphoma CD30+ ALK1- with Complete Response to Brentuximab Vedotin and High-Dose Methotrexate Gulf Journal of Oncology 1(33): 87-90
Dadacaridou, M.; Papanicolaou, X.; Maltesas, D.; Megalakaki, C.; Patos, P.; Panteli, K.; Repousis, P.; Mitsouli-Mentzikof, C. 2007: Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 41-44
Cantwell, B.M.; Harris, A.L.; Patrick, D.; Hall, R.R. 1986: Hemorrhagic cystitis after I.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer Cancer Treatment Reports 70(4): 548-549
Takagi, T.; Sakai, C.; Oguro, M. 1993: Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2191-2194
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180